Cargando…
Mesenchymal stem cells-based therapy as a potential treatment in neurodegenerative disorders: is the escape from senescence an answer?
Aging is the most prominent risk factor contributing to the development of neurodegenerative disorders. In the United States, over 35 million of elderly people suffer from age-related diseases. Aging impairs the self-repair ability of neuronal cells, which undergo progressive deterioration. Once ini...
Autores principales: | Castorina, Alessandro, Szychlinska, Marta Anna, Marzagalli, Rubina, Musumeci, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498333/ https://www.ncbi.nlm.nih.gov/pubmed/26199588 http://dx.doi.org/10.4103/1673-5374.158352 |
Ejemplares similares
-
Tackling dipeptidyl peptidase IV in neurological disorders
por: Al-Badri, Ghaith, et al.
Publicado: (2018) -
Ameliorative Effects of PACAP against Cartilage Degeneration. Morphological, Immunohistochemical and Biochemical Evidence from in Vivo and in Vitro Models of Rat Osteoarthritis
por: Giunta, Salvatore, et al.
Publicado: (2015) -
Identification of Dysregulated microRNA Networks in Schwann Cell-Like Cultures Exposed to Immune Challenge: Potential Crosstalk with the Protective VIP/PACAP Neuropeptide System
por: Musumeci, Giuseppe, et al.
Publicado: (2018) -
The seeming paradox of adenosine receptors as targets for the treatment of Alzheimer's disease: agonists or antagonists?
por: Marzagalli, Rubina, et al.
Publicado: (2015) -
Early Alterations of PACAP and VIP Expression in the Female Rat Brain Following Spinal Cord Injury
por: Broome, Sarah Thomas, et al.
Publicado: (2023)